Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.574 USD | -2.71% | -7.52% | -23.02% |
May. 15 | Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.02% | 12.1M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.32% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics Gives CFO Mark Guerin Additional Role of Chief Operating Officer